miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
about
Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene TherapyNoncoding RNAs and pancreatic cancerMicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Role of MicroRNAs-221/222 in Digestive SystemsPancreatic Cancer, A Mis-interpreter of the Epigenetic LanguageNoncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic CancerInfluenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis.miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.TIMPs: versatile extracellular regulators in cancer.MicroRNA in pancreatic cancer.miRNA nanotherapeutics for cancer.Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma.MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).Chemoresistance in pancreatic cancer: Emerging conceptsRoles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells.MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMFmiR-29b negatively regulates MMP2 to impact gastric cancer development by suppress gastric cancer cell migration and tumor growth
P2860
Q26749037-1D151330-ADF0-439D-BFFD-F3D79E9AF201Q26774630-4CBBD5A2-0251-4499-B5F4-B7AF7F98C7C7Q26799779-539B16F4-C6D2-44AB-AD24-049D2CD32889Q26799877-2A49E145-E8FD-4296-ADCF-98B3DEA1EC48Q28079735-3E645E11-1449-4D75-9795-3366D46D3483Q30241331-DEC375B4-7476-4E87-B966-E3C8C2C8A22AQ36330378-530BD6B7-1541-411A-840A-0885705779F7Q36524003-5D8A3638-759C-411B-A41F-A7EE66DC2A6AQ36667170-A06C84D3-ED17-4CD3-AB57-E8669F58887BQ37641603-FF832B98-77FC-4ADE-B337-C6507168F802Q37643929-0D638DC2-FE96-425D-BCDA-64D977DAC218Q38785433-C713A546-204C-4465-9824-56C2FB6DDEB5Q38850617-1F45D6E9-BA6D-48F5-A250-081CD8D81BB1Q38999082-3B753C0F-D51C-4686-BBD2-79CFB9DA35B7Q40489308-636C377C-7385-4B5C-B775-5B5368FB42E4Q41922910-7A5D51F6-87AF-4363-B12B-494F174973B6Q42002078-E82E474A-CD96-40E3-BB7D-8962DD9DB53FQ47211731-6E3E885F-6103-4494-BFA3-25EACE238502Q48162293-580BEAA7-37F6-4CC4-80EF-B929ABE19977Q48225163-0D0CE3C6-DB05-4EC2-B1AA-267931F2D1E4Q52881471-1B7F9745-7743-4CF3-ACC5-2276F378AA8AQ58572238-731976FC-C55E-4C4F-AFD0-3282BFD2671FQ58594896-64492088-5990-45E1-8110-3987F2371141
P2860
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
miR-221/222 induces pancreatic ...... of matrix metalloproteinases.
@en
type
label
miR-221/222 induces pancreatic ...... of matrix metalloproteinases.
@en
prefLabel
miR-221/222 induces pancreatic ...... of matrix metalloproteinases.
@en
P2093
P2860
P356
P1433
P1476
miR-221/222 induces pancreatic ...... of matrix metalloproteinases.
@en
P2093
Dong Zhang
Huanchen Sha
Jianjun Lei
Liang Zong
Ligang Nan
Qingyong Ma
Qinhong Xu
Wanxing Duan
P2860
P304
14153-14164
P356
10.18632/ONCOTARGET.3686
P407
P577
2015-06-01T00:00:00Z